COMP <GO>
IREN vs BRK-B // EV/EBITDA & P/E VALUATION
IREN Limited (NASDAQ) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: IREN 3
— BRK-B 10
▲ EV/EBITDA & P/E VALUATION LEADER: BRK-B
LAST: $23.95 (-8.76%) • MKT CAP: $10.62B
valuation
18.3x
LAST: $542.49 (+0.10%) • MKT CAP: $1.16T
valuation
9.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IREN VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IREN | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 68.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.20% | 11.47% | -10.27 | BRK-B | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 18.3x | 9.7x | +8.62 | BRK-B | /valuation <GO> |
| Free Cash Flow Yield | -3.08% | 2.09% | -5.17 | BRK-B | /fcf-yield <GO> |
| Operating Margin | 3.50% | 27.80% | -24.30 | BRK-B | /operating-margins <GO> |
| Net Profit Margin | 17.40% | 22.30% | -4.90 | BRK-B | /net-margins <GO> |
| Revenue Growth (YoY) | 167.70% | 3.93% | +163.77 | IREN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.88 | 2.85 | -0.97 | BRK-B | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | IREN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 3.55% | +3.65 | BRK-B | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 30.2 | 66.8 | -36.63 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.61 | +0.47 | IREN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 102.6x | 24.3x | +78.26 | BRK-B | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.62B | $1.16T | -$1.15T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IREN REV | BRK-B REV | IREN GROSS % | BRK-B GROSS % | IREN FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $501.0M | $371.44B | 68.3% | — | -$327.6M | $25.04B |
| FY 2024 | $187.2M | $371.43B | 53.5% | — | -$89.6M | $11.62B |
| FY 2023 | $75.5M | $364.48B | 44.0% | — | $2.3M | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IREN // BETA 1.08
BRK-B // BETA 0.61